In this issue:
MIRV improves survival in FRα-high platinum-resistant ovarian cancer
Promising efficacy for T-DXd in HER2-expressing ovarian cancer
Prognostic value of KELIM scores
Modest PFS benefit to Olaparib rechallenge in platinum-sensitive EOC
Thromboprophylaxis during neoadjuvant chemotherapy safe and beneficial
OVAL trial of ofra-vec fails to meet efficacy endpoints
Sentinel-node biopsy cannot replace lymphadenectomy in early-stage disease
Quality of life at 12 months comparable after primary or interval debulking surgery
Improved morbidity and mortality with treatment in high-volume centres
Symptoms in pre-clinical invasive EOC
Please login below to download this issue (PDF)